Annual Total Liabilities
$249.24 M
-$97.40 M-28.10%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual total liabilities is $249.24 million, with the most recent change of -$97.40 million (-28.10%) on December 31, 2023.
- During the last 3 years, CTMX annual total liabilities has fallen by -$117.20 million (-31.98%).
- CTMX annual total liabilities is now -31.98% below its all-time high of $366.44 million, reached on December 31, 2020.
Performance
CTMX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$162.43 M
-$28.01 M-14.71%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly total liabilities is $162.43 million, with the most recent change of -$28.01 million (-14.71%) on September 30, 2024.
- Over the past year, CTMX quarterly total liabilities has dropped by -$109.97 million (-40.37%).
- CTMX quarterly total liabilities is now -55.73% below its all-time high of $366.89 million, reached on March 31, 2020.
Performance
CTMX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CTMX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.1% | -40.4% |
| 3 y3 years | -32.0% | -40.4% |
| 5 y5 years | -23.6% | -40.4% |
CTMX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.1% | at low | -53.1% | at low |
| 5 y | 5-year | -32.0% | at low | -55.7% | at low |
| alltime | all time | -32.0% | +326.3% | -55.7% | +130.4% |
CytomX Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $162.43 M(-14.7%) |
| Jun 2024 | - | $190.45 M(-12.0%) |
| Mar 2024 | - | $216.37 M(-13.2%) |
| Dec 2023 | $249.24 M(-28.1%) | $249.24 M(-8.5%) |
| Sep 2023 | - | $272.40 M(-7.4%) |
| Jun 2023 | - | $294.21 M(-8.4%) |
| Mar 2023 | - | $321.27 M(-7.3%) |
| Dec 2022 | $346.64 M(+2.0%) | $346.64 M(+75.1%) |
| Sep 2022 | - | $198.02 M(-6.3%) |
| Jun 2022 | - | $211.38 M(-7.5%) |
| Mar 2022 | - | $228.63 M(-32.7%) |
| Dec 2021 | $339.87 M(-7.3%) | $339.87 M(+30.9%) |
| Sep 2021 | - | $259.56 M(-4.4%) |
| Jun 2021 | - | $271.49 M(-5.8%) |
| Mar 2021 | - | $288.14 M(-21.4%) |
| Dec 2020 | $366.44 M(+26.3%) | $366.44 M(+12.0%) |
| Sep 2020 | - | $327.12 M(-4.8%) |
| Jun 2020 | - | $343.65 M(-6.3%) |
| Mar 2020 | - | $366.89 M(+26.4%) |
| Dec 2019 | $290.17 M | $290.17 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $290.44 M(-4.4%) |
| Jun 2019 | - | $303.78 M(-5.6%) |
| Mar 2019 | - | $321.94 M(-1.3%) |
| Dec 2018 | $326.23 M(-0.5%) | $326.23 M(+0.4%) |
| Sep 2018 | - | $325.06 M(-3.2%) |
| Jun 2018 | - | $335.81 M(+2.8%) |
| Mar 2018 | - | $326.81 M(-0.3%) |
| Dec 2017 | $327.75 M(+171.7%) | $327.75 M(-4.0%) |
| Sep 2017 | - | $341.56 M(+14.0%) |
| Jun 2017 | - | $299.62 M(+187.8%) |
| Mar 2017 | - | $104.09 M(-13.7%) |
| Dec 2016 | $120.65 M(+69.6%) | $120.65 M(+16.6%) |
| Sep 2016 | - | $103.46 M(-2.1%) |
| Jun 2016 | - | $105.67 M(+33.4%) |
| Mar 2016 | - | $79.24 M(+11.4%) |
| Dec 2015 | $71.15 M(-53.1%) | $71.15 M(-69.2%) |
| Sep 2015 | - | $230.83 M(+227.5%) |
| Jun 2015 | - | $70.49 M(-53.5%) |
| Dec 2014 | $151.60 M(+159.3%) | $151.60 M |
| Dec 2013 | $58.46 M | - |
FAQ
- What is CytomX Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics annual total liabilities year-on-year change?
- What is CytomX Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly total liabilities year-on-year change?
What is CytomX Therapeutics annual total liabilities?
The current annual total liabilities of CTMX is $249.24 M
What is the all time high annual total liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total liabilities is $366.44 M
What is CytomX Therapeutics annual total liabilities year-on-year change?
Over the past year, CTMX annual total liabilities has changed by -$97.40 M (-28.10%)
What is CytomX Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CTMX is $162.43 M
What is the all time high quarterly total liabilities for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total liabilities is $366.89 M
What is CytomX Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CTMX quarterly total liabilities has changed by -$109.97 M (-40.37%)